Centene Corporation has announced it has signed a definitive agreement to sell Magellan Specialty Health to Evolent Health. Centene said it expects to receive over $750 million in aggregate proceeds, including potential earnout. It expects to receive approximately $600 million in proceeds at closing, with at least $400 million paid in cash and the remainder paid in Evolent
AUSTIN – Attorney General Ken Paxton has announced an investigation into potential violations of law related to the pricing of the life-saving drug Insulin.
17.11.2022 - ZORYVE is now on formulary for one of the top pharmacy benefit managers serving commercially insured patients, effective November 18, 2022ZORYVE is a once-daily non-steroidal cream and the first and only topical PDE4 inhibitor approved for use in . Seite 1
The company that manages Tricare's pharmacy benefits will give thousands of independent and community pharmacies that left the network last month an opportunity to rejoin.
/PRNewswire/ Interwell Health, a physician-centered organization dedicated to reimagining kidney care, today announced the appointment of eight leaders to.